• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA ACCEL ENHANCED PLATELET, PLASMA, RBC SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA ACCEL ENHANCED PLATELET, PLASMA, RBC SET Back to Search Results
Catalog Number 80440
Device Problems Improper or Incorrect Procedure or Method (2017); Microbial Contamination of Device (2303)
Patient Problems Reaction (2414); No Code Available (3191)
Event Date 02/20/2015
Event Type  Injury  
Manufacturer Narrative
Investigation: pre-collection and disinfection and in-line diversion sets were utilized for trima devices throughout the study period at (b)(6) sites.Leukoreduction apheresis platelets were collected from the (b)(6) site utilizing pre-collection arm disinfection and in-line diversion sets for trima throughout the study period of january 2010 to december 2013.There were no confirmed septic reactions for (b)(6) during the study period.Investigation is in process.A follow-up report will be provided.Citation: bravo, m., shaz, b.H., kamel, h., vanderpool, s., tomasulo, p., custer, b., and townsend, m.(2015).Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor? transfusion, 55(9), 2113-2122.Doi:10.1111/trf.13107.
 
Event Description
During a terumo bct review of the transfusion journal article ' detection of bacterial contamination in apheresis platelets: is apheresis technology a factor?' reported that (b)(6) collected apheresis platelets using trima collection devices for a retrospective study.The 262,772 platelet collections were collected atbsi from the study period of november 2008 to february 2014.During the study period, 3 confirmed bacterial transmissions were documented from 43 suspected septic transfusion reaction reports received from hospitals served by ubs centers.One reaction was due to red blood cell (rbc) unit and two were due to platelet units.One confirmed transfusion reaction was from platelet unit collected from a trima.Per the journal article, the following patient information were collected from the 262,772 collections that was performed that the bsi sites:180,867 donors were male, 81,905 donors were female,19,897 donors were age 16-22, 104,247 donors were age 23-49, 106,339 donors were age 50-64, 32,288 donors were aged over 60, 5,136 donors were black, non-hispanic, 38,440 donors were hispanic, 2,864 donors were other, 3,168 donors were asian/pacific islander, 204,395 donors were white, 8,769 donors did not have a race a listed.The customer declined to provide additional information for the investigation such as procedural details, lot information, patient information, and patient outcome.The disposable sets are not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Per the article, 'reactions induced by platelet transfusions', v.Kiefel explains how severe septic transfusion reactions are considered rare occurrences that can happen after platelet transfusion.The article also states that severity of the reactions can be chills, vomiting,tachycardia, hypotension and in severe cases shock with hyperpyrexia.Root cause: the root cause for the patient reactions is not conclusive.Possible causes for the patient reactions include bacterial contamination from transfused platelets and/or patient diseases tate.Citation:kiefel, v.(2008).Reactions induced by platelet transfusions.Transfusion medicine and hemotherapy, 35(5), 354-358.Doi:10.1159/000151350.
 
Manufacturer Narrative
Investigation: the customer did not provide the lot number pertaining to this event, therefore a device history record (dhr) search could not be conducted for this specific incident.All lots must meet acceptance criteria before release.Investigation is in process.A follow-up report will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Type of Device
TRIMA ACCEL ENHANCED PLATELET, PLASMA, RBC SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w. collins ave
lakewood, CO 80215
3032392246
MDR Report Key6950160
MDR Text Key89363644
Report Number1722028-2017-00402
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK170059
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 10/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number80440
Other Device ID Number05020583804401
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/21/2017
Initial Date FDA Received10/13/2017
Supplement Dates Manufacturer Received01/30/2018
02/21/2018
Supplement Dates FDA Received02/02/2018
02/26/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-